Literature DB >> 7591108

Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells.

E Wintermeyer1, B Ludwig, M Steinert, B Schmidt, G Fischer, J Hacker.   

Abstract

Legionella pneumophila, the causative agent of Legionnaires' disease, is able to survive intracellularly in eukaryotic cells such as monocytes, macrophages, and protozoan organisms. The Mip (macrophage infectivity potentiator) protein represents a factor of L. pneumophila necessary for optimal intracellular survival. Interestingly, Mip belongs to the substance class of FK 506-binding proteins and exhibits peptidyl-prolyl cis/trans isomerase (PPIase) activity that can be inhibited by the immunosuppressant FK506. In order to identify amino acids most likely to be involved in the enzymatic activity of Mip, site-directed mutagenized Mip proteins were constructed and characterized. It was shown that an Asp-142 to Leu-142 mutation and a Tyr-185 to Ala-185 substitution resulted in strongly reduced PPIase activity of the recombinant Mip proteins (5.3 and 0.6% of the activity of the wild-type Mip, respectively). Genes coding for the wild-type and for site-directed-mutagenized Mip proteins were used to complement three different Mip-negative mutants of the L. pneumophila Corby, Philadelphia I, and Wadsworth. While Mip protein expression could be restored in the corresponding complementants, significant Mip-specific PPIase activity could be detected only in Mip mutants complemented with wild-type mip genes. To investigate the influence of the PPIase activity of Mip on intracellular survival of L. pneumophila, invasion assays were performed using the macrophage-like cell line U937, human blood monocytes, and Acanthamoeba castellanii. The Mip-negative mutants were approximately 50- to 100-fold less infective for A. castellanii and for human mononuclear phagocytes in vitro compared with their isogenic Mip-positive parental strains. The wild-type invasion rate could be restored by introducing an intact copy of the mip gene into Mip-negative strains. In addition, no differences in intracellular survival were observed between the wild-type isolates and the Legionella strains exhibiting strongly reduced PPIase activity. These data indicated that the enzymatic activity of Mip does not contribute to intracellular survival of L. pneumophila.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591108      PMCID: PMC173657          DOI: 10.1128/iai.63.12.4576-4583.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity.

Authors:  G Fischer; H Bang; B Ludwig; K Mann; J Hacker
Journal:  Mol Microbiol       Date:  1992-05       Impact factor: 3.501

2.  Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex.

Authors:  R A Aldape; O Futer; M T DeCenzo; B P Jarrett; M A Murcko; D J Livingston
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

Review 3.  Virulence factors of the family Legionellaceae.

Authors:  J N Dowling; A K Saha; R H Glew
Journal:  Microbiol Rev       Date:  1992-03

4.  Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages.

Authors:  N P Cianciotto; B S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

5.  Selection of bacterial virulence genes that are specifically induced in host tissues.

Authors:  M J Mahan; J M Slauch; J J Mekalanos
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

6.  Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila.

Authors:  K H Berger; R R Isberg
Journal:  Mol Microbiol       Date:  1993-01       Impact factor: 3.501

7.  Nucleotide sequence analysis of the Legionella micdadei mip gene, encoding a 30-kilodalton analog of the Legionella pneumophila Mip protein.

Authors:  J M Bangsborg; N P Cianciotto; P Hindersson
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Identification of a Legionella pneumophila locus required for intracellular multiplication in human macrophages.

Authors:  A Marra; S J Blander; M A Horwitz; H A Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 9.  The mechanism of action of cyclosporin A and FK506.

Authors:  S L Schreiber; G R Crabtree
Journal:  Immunol Today       Date:  1992-04

10.  Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin.

Authors:  J U Rahfeld; K P Rücknagel; B Schelbert; B Ludwig; J Hacker; K Mann; G Fischer
Journal:  FEBS Lett       Date:  1994-09-26       Impact factor: 4.124

View more
  33 in total

Review 1.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Clinical and environmental isolates of Legionella pneumophila serogroup 1 cannot be distinguished by sequence analysis of two surface protein genes and three housekeeping genes.

Authors:  Helena Aurell; Pierre Farge; Hélène Meugnier; Manolo Gouy; Françoise Forey; Gérard Lina; François Vandenesch; Jerome Etienne; Sophie Jarraud
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

3.  Protein preparation, crystallization and preliminary X-ray crystallographic analysis of SMU.961 protein from the caries pathogen Streptococcus mutans.

Authors:  Xiong-Zhuo Gao; Lan-Fen Li; Xiao-Dong Su; XiaoJun Zhao; Yu-He Liang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-09-19

4.  A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins.

Authors:  Darren W Begley; David Fox; Dominic Jenner; Christina Juli; Phillip G Pierce; Jan Abendroth; Muigai Muruthi; Kris Safford; Vanessa Anderson; Kateri Atkins; Steve R Barnes; Spencer O Moen; Amy C Raymond; Robin Stacy; Peter J Myler; Bart L Staker; Nicholas J Harmer; Isobel H Norville; Ulrike Holzgrabe; Mitali Sarkar-Tyson; Thomas E Edwards; Donald D Lorimer
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 5.  Invasion of protozoa by Legionella pneumophila and its role in bacterial ecology and pathogenesis.

Authors:  Y Abu Kwaik; L Y Gao; B J Stone; C Venkataraman; O S Harb
Journal:  Appl Environ Microbiol       Date:  1998-09       Impact factor: 4.792

6.  Characterization of a new region required for macrophage killing by Legionella pneumophila.

Authors:  G Segal; H A Shuman
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

Review 7.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

8.  Mycobacterium avium bacilli grow saprozoically in coculture with Acanthamoeba polyphaga and survive within cyst walls.

Authors:  M Steinert; K Birkness; E White; B Fields; F Quinn
Journal:  Appl Environ Microbiol       Date:  1998-06       Impact factor: 4.792

9.  The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development.

Authors:  Isobel H Norville; Katherine O'Shea; Mitali Sarkar-Tyson; Suxin Zheng; Richard W Titball; Gabriele Varani; Nicholas J Harmer
Journal:  Biochem J       Date:  2011-08-01       Impact factor: 3.857

10.  Subinhibitory concentrations of antimicrobial agents reduce the uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 cells by altering the expression of virulence-associated antigens.

Authors:  P C Lück; J W Schmitt; A Hengerer; J H Helbig
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.